SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.589
AS - Asia 27.472
EU - Europa 21.570
SA - Sud America 4.522
AF - Africa 605
OC - Oceania 75
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 2
Totale 107.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 52.591
SG - Singapore 10.340
FI - Finlandia 6.702
CN - Cina 6.576
IT - Italia 4.421
BR - Brasile 3.473
VN - Vietnam 2.738
UA - Ucraina 2.506
HK - Hong Kong 2.410
DE - Germania 2.164
TR - Turchia 1.624
GB - Regno Unito 1.473
FR - Francia 961
BD - Bangladesh 930
SE - Svezia 778
RU - Federazione Russa 726
PL - Polonia 662
JP - Giappone 630
IN - India 546
CA - Canada 421
MX - Messico 413
ID - Indonesia 351
AR - Argentina 348
NL - Olanda 228
IQ - Iraq 220
ZA - Sudafrica 198
EC - Ecuador 179
ES - Italia 173
CO - Colombia 166
PK - Pakistan 165
BE - Belgio 123
VE - Venezuela 114
AT - Austria 110
PH - Filippine 101
SA - Arabia Saudita 94
UZ - Uzbekistan 91
MY - Malesia 90
MA - Marocco 86
CL - Cile 77
LT - Lituania 71
CZ - Repubblica Ceca 70
IE - Irlanda 67
PY - Paraguay 66
EG - Egitto 65
AE - Emirati Arabi Uniti 59
AU - Australia 58
CH - Svizzera 56
TN - Tunisia 55
KE - Kenya 53
KR - Corea 51
JO - Giordania 42
PE - Perù 41
JM - Giamaica 35
TH - Thailandia 32
UY - Uruguay 32
IL - Israele 29
OM - Oman 29
AL - Albania 28
RO - Romania 28
DZ - Algeria 27
KZ - Kazakistan 27
TW - Taiwan 27
ET - Etiopia 25
IR - Iran 24
AZ - Azerbaigian 22
LK - Sri Lanka 22
NP - Nepal 22
SN - Senegal 22
BG - Bulgaria 21
CR - Costa Rica 21
LB - Libano 21
RS - Serbia 21
GE - Georgia 20
GR - Grecia 20
HU - Ungheria 20
PT - Portogallo 19
HR - Croazia 18
KG - Kirghizistan 18
PS - Palestinian Territory 18
BO - Bolivia 16
NO - Norvegia 16
NZ - Nuova Zelanda 16
HN - Honduras 14
BH - Bahrain 13
DO - Repubblica Dominicana 13
GT - Guatemala 13
KW - Kuwait 13
TT - Trinidad e Tobago 13
EU - Europa 12
PA - Panama 12
MD - Moldavia 11
NI - Nicaragua 11
AM - Armenia 10
BA - Bosnia-Erzegovina 10
CI - Costa d'Avorio 10
DK - Danimarca 10
SY - Repubblica araba siriana 10
XK - ???statistics.table.value.countryCode.XK??? 10
BY - Bielorussia 9
CY - Cipro 9
Totale 107.652
Salva come PNG Salva come JPEG
Città #
Singapore 6.397
Helsinki 6.052
Ashburn 5.786
Fairfield 5.338
Woodbridge 5.001
Houston 3.202
Jacksonville 2.711
San Jose 2.498
Chandler 2.390
Hong Kong 2.364
Seattle 2.134
Ann Arbor 2.106
Wilmington 1.878
Santa Clara 1.823
Beijing 1.777
Cambridge 1.776
Dallas 1.699
Izmir 960
Ho Chi Minh City 896
Nanjing 872
New York 761
Princeton 751
Los Angeles 675
Warsaw 622
Hanoi 614
Tokyo 587
Lauterbourg 550
San Diego 480
Boardman 463
Munich 431
Ferrara 422
Milan 418
Council Bluffs 348
São Paulo 325
Shanghai 289
Mexico City 266
Shenyang 264
Rome 248
Nanchang 245
Jakarta 234
Moscow 219
London 208
Chicago 205
Hefei 169
Tianjin 169
Changsha 156
Buffalo 155
Falls Church 155
Orem 150
Hebei 147
Jiaxing 147
Turku 139
Bremen 136
Bologna 135
Redwood City 132
San Mateo 122
Rio de Janeiro 121
Mountain View 119
The Dalles 119
Dong Ket 118
Montreal 117
Brooklyn 116
Brussels 115
Chennai 110
Naples 109
Addison 107
Frankfurt am Main 107
Toronto 106
Da Nang 104
Haiphong 103
Johannesburg 103
Jinan 101
Phoenix 98
Nuremberg 93
Zhengzhou 93
Atlanta 88
Tashkent 86
San Francisco 83
Norwalk 82
Stockholm 82
Dearborn 81
Baghdad 80
Guangzhou 79
Verona 76
Falkenstein 75
Columbus 74
Manchester 74
Washington 73
Boston 72
Denver 72
Belo Horizonte 67
Ningbo 65
Quito 65
Amsterdam 64
Kunming 63
Philadelphia 63
Curitiba 60
Mumbai 59
Brasília 56
Des Moines 56
Totale 73.051
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 2.941
17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells 2.136
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.056
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.840
Il lungo cammino degli inibitori dell'enzima di conversione dell'angiotensina nella lotta per le malattie cardiovascolari 543
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 430
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 421
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 407
Valutazione ecocardiografica dell'insufficienza mitralica nella prospettiva della riparazione valvolare 395
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 373
Left ventricular ejection fraction and heart failure: an indissoluble marriage? 373
The Notch pathway: a novel therapeutic target for cardiovascular diseases? 370
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 358
Scompenso cardiaco con frazione di eiezione intermedia. Alla ricerca della Terra di Mezzo? 338
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 324
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 322
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis 307
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease 302
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study 300
Poor response to clopidogrel: current and future options for its management 291
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) 282
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 279
Cardiac resynchronization therapy guided by multimodality cardiac imaging 277
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain 269
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 266
CANCER THERAPY-INDUCED CARDIOTOXICITY: ROLE OF ULTRASOUND DEFORMATION IMAGING AS AN AID TO EARLY DIAGNOSIS 265
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 263
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 263
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 262
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions 260
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 260
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 259
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study 259
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 255
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 255
The role of Notch pathway in cardiovascular diseases. 255
2013 ESH/ESC Guidelines for the management of arterial hypertension 253
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 249
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 248
Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain 244
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 244
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 243
2013 ESC guidelines on the management of stable coronary artery disease 243
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 243
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 241
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 240
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 240
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 239
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 239
KRIT1 deficiency promotes aortic endothelial dysfunction 238
Aortic valve stenosis and mitochondrial dysfunctions: Clinical and molecular perspectives 237
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 237
Reperfusion Damage - A Story of Success, Failure, and Hope 236
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 236
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 235
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry 235
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 234
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion 231
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 230
Attualità e nuove prospettive in tema di cardiogenetica 230
Uric acid and coronary artery disease: An elusive link deserving further attention 229
Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy 227
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 227
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 227
Current views on anthracycline cardiotoxicity 225
Angina and left ventricular dysfunction: can we "reduce' it? 225
Efficacy and safety of catheter ablation of atrioventricular nodal re-entrant tachycardia by means of flexible-tip irrigated catheters 224
Heart failure with preserved ejection fraction: uncertainties and dilemmas 223
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 222
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 221
Anti-anginal drugs: Systematic review and clinical implications 221
2013 ESH/ESC Guidelines for the management of arterial hypertension 221
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 220
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 219
181 QUESTIONS & ANSWERS IN HEART FAILURE Heart failure 181 Questions & Answers. 217
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 217
Current role of echocardiography in cardiac resynchronization therapy 216
Can we improve myocardial protection during ischaemic injury? 215
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 214
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 211
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 210
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry 208
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 208
null 206
99mTc-sestamibi gted -Spect evaluation of post stress left ventricular ejection fraction and volumes in hypertensive patients exhibiting a normal scintigraphic perfusion pattern 205
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry 205
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 205
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors 205
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 204
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 204
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 204
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study 204
Remote monitoring of implantable devices: Should we continue to ignore it? 204
From left ventricular ejection fraction to cardiac hemodynamics: role of echocardiography in evaluating patients with heart failure 204
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 204
Prognosis after pacemaker implantation in extreme elderly 203
Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology 203
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 202
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 202
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 202
Totale 33.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 467.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.299
Totale 473.443
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021484 0 0 0 0 0 0 0 0 0 0 0 484
2021/20227.070 323 777 577 273 413 357 359 366 296 505 753 2.071
2022/20236.078 715 190 226 668 982 900 219 634 840 60 397 247
2023/20243.481 359 433 210 120 238 490 152 206 77 160 153 883
2024/202512.621 303 307 1.107 466 1.429 1.036 462 840 2.357 1.378 1.541 1.395
2025/202642.496 3.125 1.753 4.140 4.576 4.727 2.266 3.572 2.131 9.331 4.023 1.894 958
Totale 108.851